CTD-52350-96374
3 vaccinations
2 coded responses
14 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 630 / MO
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-19
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-14
- 2021-02-20
-
2021-04-10
Survey response — 3 months, dose 2MedDRA: Psoriasis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: New onset psoriasis on face (chin, around eyes, forehead, between nose and mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-10
-
2021-11-09
Dose 3 — Pfizer-BioNTech
- 2022-01-11
-
2022-02-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-05-12
Survey response — 6 months, dose 3MedDRA: Cholecystitis, Cholelithiasis obstructive, Foot fracture, Stress fracture — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Cholecystitis, cholelithiasis with obstruction, stress fracture right footMedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-05-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-11-09 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — 3 months, dose 2
Symptoms: New onset psoriasis on face (chin, around eyes, forehead, between nose and mouth
Release 11 — 6 months, dose 3
Symptoms: Cholecystitis, cholelithiasis with obstruction, stress fracture right foot
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholecystitis | · | · | ✓ |
| SD | Cholelithiasis obstructive | · | · | ✓ |
| SD | Foot fracture | · | · | ✓ |
| SD | Psoriasis | ✓ | ✓ | ✓ |
| SD | Stress fracture | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release